Shopping Cart 0
Cart Subtotal
USD 0

University of Tokyo - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

The University of Tokyo (UTokyo) is a research university that offers undergraduate, graduate, professional and distance learning programs. The university offers courses in the field of science, agriculture, economics, law, medicine, engineering, pharmaceutical sciences, and others. It also gets funding from Japanese and foreign companies for various collaborative research projects. UTokyo partners with other institute to provide educational services. The university operates through its academic centers such as Asian Natural Environmental Science Center, Biotechnology Research Center, Center for Research and Development of Higher Education, Center for Spatial Information Science, Cryogenic Research Center, and others. UTokyo is headquartered in Bunkyo-Ku, Japan.

University of Tokyo-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Tokyo, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Tokyo, Medical Devices Deals, 2012 to YTD 2018 9

University of Tokyo, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

University of Tokyo, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Astellas Pharma, Institute of Medical Science, Chiba University and Asahi Kogyosha Enter into Research Agreement 11

Astellas Pharma Enters into Agreement with Institute of Medical Science, the University of Tokyo 12

IMSUT and Astellas Pharma Enter into Agreement 13

Sanofi Enters into Drug Discovery Agreement with University of Tokyo 14

University of Tokyo Enters Into Research Agreement With Astellas Pharma To Discover New Drugs For NTDs 15

Licensing Agreements 16

TransGenic Enters into Licensing Agreement with University of Tokyo 16

BrightPath Biotherapeutics Enters into Licensing Agreement with University of Tokyo 17

TODAI TLO Enters into Licensing Agreement with NanoCarrier 18

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 19

Qiagen Enters into Licensing Agreement with University of Tokyo for SF3B1 21

Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 22

University of Tokyo-Key Competitors 23

University of Tokyo-Key Employees 24

University of Tokyo-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

Government and Public Interest 26

Jun 15, 2018: Artificial biosynthesis yields superior steroid antibiotics 26

May 02, 2018: Variation in single amino acid impacts incidence of gastric cancer among Japanese 27

Jan 29, 2018: Blood vessel-on-a-chips show anti-cancer drug effects in human cells 28

Jan 11, 2018: NFIA identified as promising target for treating obesity 29

Nov 15, 2017: New treatment suppresses relapse of eye lymphoma in brain 30

Product News 31

Jun 13, 2018: University of Tokyo's RCAST Fujitsu and Kowa Successfully Create Promising New Compounds to Fight Drug-Resistant Cancer 31

Product Approvals 32

Jul 11, 2017: Oncolytic Virus G47delta (DS-1647) designated as Orphan Drug under Orphan Drug/Medical Device Designation System 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33


List Of Figure

List of Figures

University of Tokyo, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Tokyo, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Tokyo, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

University of Tokyo, Pharmaceuticals & Healthcare, Key Facts 2

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Tokyo, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Tokyo, Deals By Therapy Area, 2012 to YTD 2018 8

University of Tokyo, Medical Devices Deals, 2012 to YTD 2018 9

University of Tokyo, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Astellas Pharma, Institute of Medical Science, Chiba University and Asahi Kogyosha Enter into Research Agreement 11

Astellas Pharma Enters into Agreement with Institute of Medical Science, the University of Tokyo 12

IMSUT and Astellas Pharma Enter into Agreement 13

Sanofi Enters into Drug Discovery Agreement with University of Tokyo 14

University of Tokyo Enters Into Research Agreement With Astellas Pharma To Discover New Drugs For NTDs 15

TransGenic Enters into Licensing Agreement with University of Tokyo 16

BrightPath Biotherapeutics Enters into Licensing Agreement with University of Tokyo 17

TODAI TLO Enters into Licensing Agreement with NanoCarrier 18

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 19

Qiagen Enters into Licensing Agreement with University of Tokyo for SF3B1 21

Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 22

University of Tokyo, Key Competitors 23

University of Tokyo, Key Employees 24

University of Tokyo, Subsidiaries 25

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

University of Tokyo, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

The University of Tokyo (UTokyo) is a research university that offers undergraduate, graduate, professional and distance learning programs. The university offers courses in the field of science, agriculture, economics, law, medicine, engineering, pharmaceutical sciences, and others. It also gets funding from Japanese and foreign companies for various collaborative research projects. UTokyo partners with other institute to provide educational services. The university operates through its academic centers such as Asian Natural Environmental Science Center, Biotechnology Research Center, Center for Research and Development of Higher Education, Center for Spatial Information Science, Cryogenic Research Center, and others. UTokyo is headquartered in Bunkyo-Ku, Japan.

University of Tokyo-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Tokyo, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Tokyo, Medical Devices Deals, 2012 to YTD 2018 9

University of Tokyo, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

University of Tokyo, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Astellas Pharma, Institute of Medical Science, Chiba University and Asahi Kogyosha Enter into Research Agreement 11

Astellas Pharma Enters into Agreement with Institute of Medical Science, the University of Tokyo 12

IMSUT and Astellas Pharma Enter into Agreement 13

Sanofi Enters into Drug Discovery Agreement with University of Tokyo 14

University of Tokyo Enters Into Research Agreement With Astellas Pharma To Discover New Drugs For NTDs 15

Licensing Agreements 16

TransGenic Enters into Licensing Agreement with University of Tokyo 16

BrightPath Biotherapeutics Enters into Licensing Agreement with University of Tokyo 17

TODAI TLO Enters into Licensing Agreement with NanoCarrier 18

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 19

Qiagen Enters into Licensing Agreement with University of Tokyo for SF3B1 21

Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 22

University of Tokyo-Key Competitors 23

University of Tokyo-Key Employees 24

University of Tokyo-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

Government and Public Interest 26

Jun 15, 2018: Artificial biosynthesis yields superior steroid antibiotics 26

May 02, 2018: Variation in single amino acid impacts incidence of gastric cancer among Japanese 27

Jan 29, 2018: Blood vessel-on-a-chips show anti-cancer drug effects in human cells 28

Jan 11, 2018: NFIA identified as promising target for treating obesity 29

Nov 15, 2017: New treatment suppresses relapse of eye lymphoma in brain 30

Product News 31

Jun 13, 2018: University of Tokyo's RCAST Fujitsu and Kowa Successfully Create Promising New Compounds to Fight Drug-Resistant Cancer 31

Product Approvals 32

Jul 11, 2017: Oncolytic Virus G47delta (DS-1647) designated as Orphan Drug under Orphan Drug/Medical Device Designation System 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33


List Of Figure

List of Figures

University of Tokyo, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Tokyo, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Tokyo, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

University of Tokyo, Pharmaceuticals & Healthcare, Key Facts 2

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Tokyo, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Tokyo, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Tokyo, Deals By Therapy Area, 2012 to YTD 2018 8

University of Tokyo, Medical Devices Deals, 2012 to YTD 2018 9

University of Tokyo, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Astellas Pharma, Institute of Medical Science, Chiba University and Asahi Kogyosha Enter into Research Agreement 11

Astellas Pharma Enters into Agreement with Institute of Medical Science, the University of Tokyo 12

IMSUT and Astellas Pharma Enter into Agreement 13

Sanofi Enters into Drug Discovery Agreement with University of Tokyo 14

University of Tokyo Enters Into Research Agreement With Astellas Pharma To Discover New Drugs For NTDs 15

TransGenic Enters into Licensing Agreement with University of Tokyo 16

BrightPath Biotherapeutics Enters into Licensing Agreement with University of Tokyo 17

TODAI TLO Enters into Licensing Agreement with NanoCarrier 18

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 19

Qiagen Enters into Licensing Agreement with University of Tokyo for SF3B1 21

Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 22

University of Tokyo, Key Competitors 23

University of Tokyo, Key Employees 24

University of Tokyo, Subsidiaries 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

University of Tokyo, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

chat_bubbleLet's Chat